It is more common than many service members expect: one urinalysis comes back positive, a later sample comes back negative, and the member assumes the conflict cancels itself out. During an administrative separation based on a positive drug test, inconsistent results across multiple tests do not resolve themselves automatically. They become a question of evidence and weight that the separation authority and any administrative board must work through. Understanding how that process treats conflicting results helps a member respond effectively rather than rely on a mistaken assumption.
The administrative framework
Enlisted administrative separations are governed by Department of Defense Instruction 1332.14, with parallel guidance for officers in DoD Instruction 1332.30 and service-specific regulations layered on top. The technical procedures for the drug testing program itself are set out in DoD Instruction 1010.16. A separation based on drug abuse is processed as misconduct, and depending on the member’s length of service and the characterization at issue, the member may be entitled to have the matter heard by an administrative separation board.
The crucial point is that an administrative separation is not a criminal trial. The board or separation authority decides whether the misconduct is supported by a preponderance of the evidence, meaning more likely than not, rather than beyond a reasonable doubt. The focus is on whether the member should be retained or separated and how any discharge should be characterized, not on assigning criminal guilt. That lower standard shapes how inconsistent results are weighed.
Why a later negative does not erase an earlier positive
The single most important concept for a member facing conflicting tests is that the so-called retest is usually not what it sounds like. After a positive result, a command frequently collects a second specimen and labels it a retest. In most cases this is not a re-examination of the original sample. It is an entirely new urinalysis of a fresh specimen collected days or weeks later.
That distinction matters because detection windows for many drugs are measured in days, not weeks. By the time the command receives the first positive and directs a second collection, the substance that drove the original result may no longer be present even if use actually occurred. A negative on the later sample is therefore consistent with simply no further use after the first event. It does not, standing alone, prove that the first laboratory result was wrong, and it typically …